A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Submitted |
---|---|
Submitter | Slovenia |
Submitter email | biocidi.uzk@gov.si |
Regulatory programme |
|
Classification
Proposed harmonised classification by the dossier submitter |
|
---|---|
Proposed specific concentration limits by the dossier submitter | oral: ATE = 175 mg/kg bw Skin Sens 1A; H317: C ≥ 0.0015% |
Intention timeline
Date of intention | 2022-01-19 |
---|---|
Expected date of submission | 2022-01-31 |
Submitted for accordance check | 2022-01-31 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Nov. 21, 2022
- Deadline for commenting: 2023-01-13
- Final submission date: 2022-09-29
- Hazard classes open for commenting: Physical hazards Carcinogenicity Germ cell mutagenicity Reproductive toxicity Acute Toxicity - inhalation Acute Toxicity - dermal Acute Toxicity - oral Aspiration hazard Specific target organ toxicity – single exposure Specific target organ toxicity – repeated exposure Skin corrosion/irritation Serious eye damage/eye irritation Respiratory sensitisation Skin Sensitisation Hazardous to the aquatic environment Hazardous to the ozone layer
- Legal deadline for opinion adoption: 2024-03-30
- Status: Submitted → Consultation
- Start of consultation: 2022-11-14
Jan. 18, 2023
- Submitter email: biocidi.uzk@gov.si → reach.mz@gov.si
This version
June 24, 2022
- Proposed specific concentration limits by the dossier submitter: oral: ATE = 175 mg/kg bw Skin Sens 1A; H317: SCL ≥ 0.0015% → oral: ATE = 175 mg/kg bw Skin Sens 1A; H317: C ≥ 0.0015%
Add the related substance to your watchlist to monitor this regulatory record.